QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,457 signal articles · 534 in last 24h · 104,698 total before filter · latest 19m ago
534last 24h
2535last 7d
482● bullish (7d)
260● bearish (7d)
199publishers
AllMacro190Earnings1565M&A139Regulatory17Product8Analyst28
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Bloomberg15d agoneutral
JPMorgan, Goldman Set for $100 Million Paydays on SoftBank’s Record Loan

(Bloomberg) -- Global banks are poised to reap a windfall from SoftBank Group Corp.’s unprecedented borrowing binge as they fund the debt-laden conglomerate’s enormous artificial intelligence bet.Most Read from BloombergApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesChina AI Sensation Moonshot’s Gamble on Big Models Pays OffYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawUS Allies in Persian Gul

GSJPMSPCX
Treasury Yields Higher Ahead of Fed Meeting
Barrons.com15d agoneutral
Treasury Yields Higher Ahead of Fed Meeting

Treasury's fell sending yields higher, concluding a day of light U.S. economic data ahead of the Federal Reserve's interest rate meeting next week. Brent crude futures added 2% to settle above $90 a barrel.

^TNX
Bloomberg15d agoneutral
OpenAI Names BNY, Nubank CEOs to Board Ahead of IPO

(Bloomberg) -- OpenAI has appointed two financial services executives to its board of directors, drawing on their experience as the company moves toward a Wall Street debut. Most Read from BloombergApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesChina AI Sensation Moonshot’s Gamble on Big Models Pays OffYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Th

NU
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Reuters Videos15d agoneutralVIDEO
Novo sues Lilly, claiming misleading ads in weight-loss drug battle

<body><p>STORY: :: Novo Nordisk claims misleading ads in Eli Lilly weight-loss drug lawsuit</p><p>:: July 21, 2026</p><p>:: Maggie Fick, European Pharma Industry Correspondent</p><p>"Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising and claiming its weight-loss medicines outperform Novo's drugs." //</p><p>"Novo is alleging in its suit that Lilly's advertisements compare weight-loss results of about 50 pounds for its drug Zepbound with about 33 pounds for Wegovy, even though no head-to-head clinical trial has compared the highest approved doses of the medicines."</p><p>"Pharmaceutical companies regularly sue each other over claims related to patent infringement, for example, but false advertising suits, such as the one filed today, are less common."</p><p>"Novo Nordisk was first to market with its weight-loss injection Wegovy several years ago, but it later lost the lead to Eli Lilly, after that company launched a rival injection called Zepbound in the United States. Last year, Novo replaced its CEO and was forced to issue multiple profit warnings as it fell further behind Eli Lilly in this really competitive and booming obesity drug market, which analysts expect to be worth more than $100 billion by 2030. This year, Novo has actually sort of landed a counterpunch with its oral Wegovy pill. It was able to launch that drug ahead of Eli Lilly. Lilly has, in April, launched its own pill, a weight-loss pill. But Novo has managed to keep up strong sales even since the launch of Lilly's pill."</p><p>"Both companies report quarterly results in the next couple of weeks."</p><p>:: Novo Nordisk</p><p>:: Eli Lilly</p><p>The Danish company filed the lawsuit in U.S. District Court ‌in New Jersey, alleging Lilly violated federal and state false advertising and unfair competition laws, including the Lanham Act, through nationwide advertising campaigns for obesity drug Zepbound and diabetes treatment Mounjaro.</p><p>Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo's Wegovy and Ozempic while omitting newer, higher-dose versions that Novo says deliver greater weight loss.</p><p>But Indianapolis-based Eli Lilly said it stands firmly behind its ads, which are based on the results of its SURMOUNT-5 trial. That ⁠trial — completed in 2024 — compared patients on 10 mg or 15 mg of Lilly's Zepbound to patients on 1.7 mg or 2.4 mg doses of Wegovy. The FDA approved ​a 7.2 mg dose of Wegovy in March of this year.</p></body>

LLYNVO
GM Boosts 2026 Outlook on Premium Pricing for Big Trucks
Bloomberg15d agoneutralVIDEO
GM Boosts 2026 Outlook on Premium Pricing for Big Trucks

General Motors&nbsp;raised its full-year profit forecast by another $500 million after beating second-quarter earnings estimates, powered by stronger margins on its largest vehicles and lower tariff costs.&nbsp;Bloomberg's David Welch joins to discuss.

GM
Bloomberg15d agoneutral
Trump Extends Pardons to Companies, Echoing a 17th Century King

(Bloomberg) -- Ryan LaLone received a pardon this month for a conviction tied to tampering with diesel emissions systems. Just as importantly, so did his company. Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeIran Says Mediators Stepping In After Days of US ClashesThe twin reprieves

TSLA
Amazon's $595 titanium luxury watch is a Seiko on the inside
TheStreet15d agoneutral
Amazon's $595 titanium luxury watch is a Seiko on the inside

Luxury watches seem to remain popular, even during times of financial crisis and tumult. That's probably because watches are often purchased as the representation of a personal or professional milestone. Those moments don't simply stop happening because the job market is slow or because inflation ...

AMZN
Novo Nordisk sues Eli Lilly over GLP-1 drug advertising claims
Proactive15d agoneutral
Novo Nordisk sues Eli Lilly over GLP-1 drug advertising claims

Novo Nordisk (NYSE:NVO) has filed a federal lawsuit against Eli Lilly, alleging that its rival’s advertising campaigns for blockbuster GLP-1 obesity and diabetes drugs mislead consumers about the effectiveness of competing treatments. The complaint, filed on July 21, 2026, in the US District...

LLYNVO
Bloomberg15d agoneutral
Trump Has Spent 0.6% of His $401 Million Super PAC to Boost GOP

(Bloomberg) -- President Donald Trump’s super political action committee is sitting on $401 million in cash, more than any other super PAC, but has spent just $2.3 million — 0.6% of that total — to help Republicans win elections.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strike

GEMI
Bloomberg15d agoneutral
SpaceX’s Great Unlocking Begins With $116 Billion Share Release

(Bloomberg) -- SpaceX has set the stage for one of the largest share unlocks in capital markets history, with as much as $116 billion worth of stock becoming eligible for sale for the first time next month.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Ca

SPCX
Bloomberg15d agoneutral
AMC Rolls Out Red Carpet for Debt Investors to Trumpet Rebound

(Bloomberg) -- Dozens of SUVs descended upon AMC’s Lincoln Square theater in New York Monday for an exclusive screening of The Odyssey. But it wasn’t the typical celebrity crowd streaming out of the cars and onto a red carpet.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes I

AMC
Bloomberg15d agoneutral
IRS Chief Denies Report He Spied on Colleagues While at JPMorgan

(Bloomberg) -- Frank Bisignano, the head of the Internal Revenue Service and Social Security Administration, denied a report in the Wall Street Journal that he spied on colleagues while at JPMorgan Chase.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Camp

JPMWFC
Trump imposes 50% tariffs on Canada: Markets are accustomed to 'heavy hand' tactic
Yahoo Finance Video15d agoneutralVIDEO
Trump imposes 50% tariffs on Canada: Markets are accustomed to 'heavy hand' tactic

The Trump administration has imposed a 50% tariff on certain Canadian goods, which includes imports previously protected under the United States-Mexico-Canada Agreement (USMCA). Winthrop Capital CIO Adam Cooné is joined by Yahoo Finance Senior Reporters Brooke DiPalma and Ines Ferre in gauging the muted market reaction to these new trade policies, how the US consumer is faring, and what earnings from General Motors (GM) may indicate about consumer health.

GM
Bloomberg15d agoneutral
China’s Moonshot in Talks on Pre-IPO Funds at $50 Billion Value

(Bloomberg) -- Moonshot AI is preparing to begin discussions in August on a final round of fundraising before listing in Hong Kong, capitalizing on the excitement around its latest model to raise capital at a valuation of as much as $50 billion.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than

GOOGGOOGLMETA
Bloomberg15d agoneutral
BlackRock vs BlackRock: Aston Martin Debt Revamp Risks In-House Clash

(Bloomberg) -- A potential debt revamp at Aston Martin Lagonda Global Holdings Plc is setting the stage for an unusual battle between different divisions of asset management giant BlackRock Inc.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After

BLK
Bloomberg15d agoneutral
Z.AI to Use Only Chinese AI Chips at New Giant Data Center

(Bloomberg) -- Z.AI has completed construction of a major data center that it plans to fill only with Chinese-made chips, a step forward in Beijing’s efforts to shift away from restricted Nvidia Corp. silicon for future AI development.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS

BABA
Bloomberg15d agoneutral
Kalshi Seeks Approval for Perpetual Futures Tied to Gold, Silver

(Bloomberg) -- Kalshi Inc. is seeking approval to expand precious-metals trading on its platform with a popular type of derivative that never expires for gold, silver and platinum.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Campaign After Troops Killed

ICE
Bloomberg15d agoneutral
Biotech IPO Gains Crush AI Listings With Standout 55% Return

(Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Cam

ABBVSPCXVRTX
Investing.com15d agoneutral
Novo Nordisk sues Eli Lilly in high-stakes GLP-1 advertising feud

Investing.com -- The clash between pharma titans Novo Nordisk and Eli Lilly just escalated from the pharmacy counter to the courtroom. Novo Nordisk Inc. filed a lawsuit in the U.S. District Court for the District of New Jersey against Eli Lilly and Company and Lilly USA, LLC, alleging multiple violations of federal and state false advertising and unfair competition laws under the Lanham Act. The lawsuit takes aim at Lilly’s aggressive direct-to-consumer (DTC) advertising campaigns for its blockb

LLYNVO